KARAKTERISTIK KEJADIAN IKUTAN PASCA IMUNISASI MODERNA PADA TENAGA KESEHATAN DI SAMARINDA

Ariestya Romadhan Laksono Pratama, Crissty Magglin, Hamidah Jufrie, Nerissa Laksono Arviana, Nurul Fatimah, Muhammad Khairul Nuryanto, Rahmat Bakhtiar, Opiansyah Opiansyah

Abstract


KIPI adalah setiap kejadian medis yang tidak diharapkan terjadi pasca imunisasi, memiliki hubungan sebab akibat dengan penggunaan vaksin. Penelitian ini dilakukan untuk mengetahui karakteristik KIPI pada tenaga kesehatan di Samarinda pasca imunisasi Moderna. Penelitian ini bersifat survey deskriptif dengan pengambilan sampel secara purposive sampling. Sampel penelitian adalah tenaga kesehatan di kota Samarinda yang telah mendapatkan imunisasi Moderna yang berjumlah 105 responden. Pengambilan data dilakukan dengan kuesioner yang dibagikan secara online kepada para responden. Hasil penelitian menunjukkan bahwa KIPI terbanyak yang dialami responden adalah nyeri di lokasi suntikan (85,7%), di mana mayoritas responden mengalami nyeri berat dengan skala nyeri 7 (22,9%), dan mayoritas responden mengonsumsi parasetamol untuk meringankan gejala KIPI (62,5%). Pada penelitian juga didapatkan bahwa mayoritas responden tidak mengalami perubahan nafsu makan (70,5%), tidak mengalami perubahan pola tidur (69,5%), tidak mengalami perubahan tingkat aktivitas (62,8%); tidak mengalami perubahan mood (51,4%); serta mayoritas responden perempuan usia subur tidak mengalami perubahan pola haid (84,5%).  


Full Text:

PDF

References


Wang LS, Wang YR, Ye DW, Liu QQ. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. International Journal of Antimicrobial Agents. 2020.

WHO (World Health Organization).Global Situation. [Internet]. [cited: 13 September 2021]. Available from : https://covid19.who.int.

Kemenkes RI. Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit. Jakarta: Kementerian Kesehatan Republik Indonesia Direktorat Jenderal Pencegahan dan Pengendalian Penyakit; 2021.

Kementrian Kesehatan. Buku Ajar Imunisasi. Jakarta: Pusat Pendidikan dan Pelatihan Tenaga Kesehatan Kementerian Kesehatan RI; 2014.

Public Health Ontario. Adverse Events Following Immunization (AEFIs) for COVID-19 in Ontario: September 4, 2021.Ontario.2020.

Kholidiyah D, Sutomo, Kushayati N. Hubungan persepsi masyarakat tentang vaksin covid-19 dengan kecemasan saat akan menjalani vaksinasi covid-19. Jurnal Keperawatan.2021:8-20.

Badan PPSDM Kesehatan. Data SDM Kesehatan yang didayagunakan di Fasilitas Pelayanan Kesehatan (Fasyankes) di Indonesia. 2020. available in http://bppsdmk.kemkes.go.id/info_sdmk/info/.

Boniol M, Mclsaac M,Xu L,et al. WHO:Gender aquity in the health workforce: Analysis of 104 countries.2019.

Badan Pusat Statistik. Jumlah Penduduk Menurut Kelompok Umur dan Jenis Kelamin 2020. [Internet]. [cited: 14 Oktober 2021]. Available from https://www.bps.go.id/indikator/indikator/view_data_pub/0000/api_pub/YW40a21pdTU1cnJxOGt6dm43ZEdoZz09/da_03/1.

Ramadhaniah, Julia M, Huriyati E. Durasi Tidur, Asupan Energi, dan aktivitas fisik dengan kejadian obesitas pada tenaga Kesehatan puskesmas. Jurnal Gizi Klinik Indonesia. 2014; 11 (2) : 85-96.

Kemenkes RI. Surat edaran no. Hk.02.01/i/2529/2021 tentang vaksinasi covid-19 bagi penyintas. P. 2.2021.

Kemenkes RI. Surat edaran no. Hk.02.02/ii/368/2021 tentang pelaksanaan vaksinasi covid-19 pada kelompok sasaran lansia, komorbid dan penyintas covid-19 serta sasaran tunda. 2021.

WHO (World Health Organization). The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know.2021.

Barda N, Dagan N, Shlomo YB, Kepten E. Safety of the BNT162b2 Mrna Covid-19 Vaccine in a Nationwide Setting. The New England Journal of Medicine. 2021.

World Health Organization (WHO). Dasar-Dasar Keamanan Vaksin; Kejadian ikutan pasca imunisasi Pelatihan melalui elektronik. 2021. Available in https://in.vaccine-safety-training.org/vaccine-reactions.html

ModernaTX Inc. Fact sheet for healthcare providers administering vaccine (vaccination providers).2021.

Guyton AC, Hall JE. Buku Ajar Fisiologi Kedokteran Edisi 12. Jakarta: Penerbit Buku Kedokteran EGC.2014.

Center for Disease Control and Prevention (CDC). The Moderna COVID-19 Vaccine’s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events. 2021. available in https://www.cdc.gov/vaccines/covid 19/info-by product/moderna/reactogenicity.html.

Kadali R, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2021; 06 :376–381.

Hervé C, Laupèze B, Giudice GD, Didierlaurent AM, Silva FT. The How’s and What’s of Vaccine Reactogenicity. Nature Partner Journals Vaccine, Available in https://doi.org/10.1038/s41541-019-0132-6. 2019.

McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Freeman EE. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 case. Journal American Academy OfDermatology. 2021: 46-55.

National Centre For Immunisation Research and Surveillance. Injection Site Reaction. 2020. July, 1–2. https://doi.org/10.32388/gv8yre

Australian Government. After your Spikevax vaccination. September, 2–4. 2021.

World Health Organization (WHO). The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know.2021.

Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases, 21(7), 939–949. 2021. https://doi.org/10.1016/S1473-3099(21)00224-3

Norwegian Medicines Agencies. Reported suspected adverse reactions to COVID- Table of contents. 2021: 1–13.

Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, Shimabukuro, T. First Month of COVID-19 Vaccine Safety Monitoring-United States, December 14, 2020–January 13.2021. Morbidity and Mortality Weekly Report.

Wardhani PA. Aliran limfatik daerah kepala dan leher serta aspek klinisnya. Jurnal Ipa, 6, 2015: 33–51. available in http://journal.unair.ac.id/download-fullpapers-thtklcf24d49744full.pdf

World Health Organization (Who). Critical Sex And Gender Considerations For Equitable Research, Development And Delivery Of Covid-19 Vaccines. Backround Paper. Nomor 29.2021.

Winulyo EB. Teknis Pelaksanaan Vaksin Covid dan Antisipasi KIPI.2021.

Centers of Disease Control and Prevention (CDC). Possible Side Effects After Getting a COVID-19 Vaccine. Retrieved from COVID-19.2021. available in https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html

National Institute of Health. Covid-19 Vaccines and The Menstrual Cycle. Retrieved from National Institute of Health Covid-19. 2021. Available in https://covid19.nih.gov/news-and-stories/covid-19-vaccines-and-menstrual-cycle




DOI: http://dx.doi.org/10.30872/jkm.v9i1.6989

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Jurnal Kedokteran Mulawarman

Creative Commons License
Jurnal Kedokteran Mulawarman by Faculty of Medicine Mulawarman University is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.